Toggle navigation
Home
Search
Services
Blog
Contact
About
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Androgen Receptor in B Cell Development and Functions
Chlamydial Immunity and Pathogenesis
Pyridine Nucleosides, Nucleotides of Biological Interest
Transport and Action of Thyroid Hormones
Meeting: The Developmental Biology of the Sea Urchin XXIV, The Marine Biological Laboratory, Woods Hole, MA, April 5-9, 2017
Recently added grants:
Targeting lymph node metastases to prevent cancer progression
Smart and self-reporting clinical nano carriers for drug delivery
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
Northwestern University Lead Academic Participating Site
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N02CM72202-2-0-1
Application #
7590582
Study Section
Project Start
2007-06-01
Project End
2012-05-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N02 CA
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
/ Research Triangle Institute
$688,286
NIH 2007
N01 CA
Analysis of Anti-Cancer Chemicals and Pharmaceutical Formulations
Hines, John /
$622,262
NIH 2007
N01 CA
Analysis of Anti-Cancer Chemicals and Phamaceutical Formulations
/
Comments
Be the first to comment on this grant